Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-24-000204
Filing Date
2024-08-14
Accepted
2024-08-14 10:34:08
Documents
29
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cncl0806form10q.htm   iXBRL 10-Q 231488
2 EXHIBIT 31.1 cncl0806form10qexh31_1.htm EX-31.1 8164
3 EXHIBIT 31.2 cncl0806form10qexh31_2.htm EX-31.2 8110
4 EXHIBIT 32.1 cncl0806form10qexh32_1.htm EX-32.1 3864
  Complete submission text file 0001554795-24-000204.txt   1141734

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cncl-20240630.xsd EX-101.SCH 9550
6 XBRL CALCULATION FILE cncl-20240630_cal.xml EX-101.CAL 20101
7 XBRL DEFINITION FILE cncl-20240630_def.xml EX-101.DEF 15442
8 XBRL LABEL FILE cncl-20240630_lab.xml EX-101.LAB 95705
9 XBRL PRESENTATION FILE cncl-20240630_pre.xml EX-101.PRE 68182
32 EXTRACTED XBRL INSTANCE DOCUMENT cncl0806form10q_htm.xml XML 63982
Mailing Address 440 EAST 400 SOUTH STE 300 SALT LAKE CITY UT 84111
Business Address 440 EAST 400 SOUTH STE 300 SALT LAKE CITY UT 84111 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

EIN.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32363 | Film No.: 241205076
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)